with that said, i am pleased to hand the podium over to the nectar president and ceo, howard w. robbins. [applause] >> thank you. thank you. thank you, jennifer. it is great to see everyone. obviously, we're very proud of our new facility. that is a state of the art facility, 100,000-plus square feet of some of the finest research labs in the u.s., and it will really allow us to expand our groundbreaking work in the areas of oncology and pain, some areas that need help from our patients. if we bring great drugs to our patients and families through the work we do in this building, i think it will have an enormous benefit for everyone. this is not a business. this is not the it industry for the faint of heart. enormous amounts of risk have to be taken in the biotech industry, enormous amounts of human capital and economic capital have to go into building and developing new drugs. it would have a facility that is this content -- when you have a facility that is this competent and well executed, it will work very well. we have been around a number of years and it has evolved into a differen